Agramelk may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Lactic Acid is reported as an ingredient of Agramelk in the following countries:
Povidone-Iodine is reported as an ingredient of Agramelk in the following countries:
International Drug Name Search
Xinamod may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Xinamod in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Xinamod in the following countries:
International Drug Name Search
Bisoprolol Zydus may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol Zydus in the following countries:
International Drug Name Search
Tetracyclin HCL may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tetracyclin HCL in the following countries:
International Drug Name Search
Zetamax may be available in the countries listed below.
Azithromycin is reported as an ingredient of Zetamax in the following countries:
International Drug Name Search
Xyzal is a brand name of levocetirizine, approved by the FDA in the following formulation(s):
A generic version of Xyzal has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Xyzal and have been approved by the FDA:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xyzal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Zinacef is a brand name of cefuroxime, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Zinacef:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zinacef. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Zinacef.
Allylestrénol may be available in the countries listed below.
Allylestrénol (DCF) is also known as Allylestrenol (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Tamoxifeno Funk may be available in the countries listed below.
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifeno Funk in the following countries:
International Drug Name Search
Gored may be available in the countries listed below.
Gliclazide is reported as an ingredient of Gored in the following countries:
International Drug Name Search
Abaktal may be available in the countries listed below.
Pefloxacin is reported as an ingredient of Abaktal in the following countries:
International Drug Name Search
Zofixi-CL may be available in the countries listed below.
Cefixime is reported as an ingredient of Zofixi-CL in the following countries:
Clavulanic Acid is reported as an ingredient of Zofixi-CL in the following countries:
International Drug Name Search
Distalene may be available in the countries listed below.
Anastrozole is reported as an ingredient of Distalene in the following countries:
International Drug Name Search
Bioflutikazon may be available in the countries listed below.
Fluticasone is reported as an ingredient of Bioflutikazon in the following countries:
International Drug Name Search
Betaferon may be available in the countries listed below.
UK matches:
Interferon beta Interferon beta-1b (a derivative of Interferon beta) is reported as an ingredient of Betaferon in the following countries:
International Drug Name Search
Ventolin Rotacaps may be available in the countries listed below.
Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Ventolin Rotacaps in the following countries:
International Drug Name Search
Bicalutamid Bluefish may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Bicalutamid Bluefish in the following countries:
International Drug Name Search
Oftan IDU may be available in the countries listed below.
Idoxuridine is reported as an ingredient of Oftan IDU in the following countries:
International Drug Name Search
Somnil may be available in the countries listed below.
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Somnil in the following countries:
International Drug Name Search
Ceftriaxona Genfar may be available in the countries listed below.
Ceftriaxone is reported as an ingredient of Ceftriaxona Genfar in the following countries:
International Drug Name Search
Meloxicam Cipla Chanelle Generics may be available in the countries listed below.
Meloxicam is reported as an ingredient of Meloxicam Cipla Chanelle Generics in the following countries:
International Drug Name Search
Cisplamol may be available in the countries listed below.
Cisplatin is reported as an ingredient of Cisplamol in the following countries:
International Drug Name Search
Fivefluro may be available in the countries listed below.
Fluorouracil is reported as an ingredient of Fivefluro in the following countries:
International Drug Name Search
Sensilux may be available in the countries listed below.
Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Sensilux in the following countries:
International Drug Name Search
Prednisone Almus may be available in the countries listed below.
Prednisone is reported as an ingredient of Prednisone Almus in the following countries:
International Drug Name Search
Beklazon may be available in the countries listed below.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beklazon in the following countries:
International Drug Name Search
In the US, Paraldehyde (paraldehyde systemic) is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics.
US matches:
USP
N05CC05
0000123-63-7
C6-H12-O3
132
Antiepileptic agent
Hypnotic and sedative agent
1,3,5-Trioxane, 2,4,6-trimethyl-
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| USP | Pharmacopoeia of the United States |
Shampoo Antiparasitário may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Tetramethrin is reported as an ingredient of Shampoo Antiparasitário in the following countries:
International Drug Name Search
Propranolol HCl Katwijk may be available in the countries listed below.
Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol HCl Katwijk in the following countries:
International Drug Name Search
Miropin may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Miropin in the following countries:
International Drug Name Search
Calmese may be available in the countries listed below.
Lorazepam is reported as an ingredient of Calmese in the following countries:
International Drug Name Search
Corotal may be available in the countries listed below.
Acetyldigoxin ß-isomer (a derivative of Acetyldigoxin) is reported as an ingredient of Corotal in the following countries:
International Drug Name Search
Lorantis may be available in the countries listed below.
Loratadine is reported as an ingredient of Lorantis in the following countries:
International Drug Name Search
Treating chronic hepatitis C virus (HCV) infection in certain patients. It must be used in combination with peginterferon and ribavirin.
Boceprevir is a hepatitis C protease inhibitor. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Boceprevir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Boceprevir. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Boceprevir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Boceprevir as directed by your doctor. Check the label on the medicine for exact dosing instructions. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Boceprevir.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Change in taste; decreased appetite; diarrhea; dizziness; dry mouth; dry skin; hair loss; headache; irritability; joint pain; nausea; tiredness; trouble sleeping; vomiting; weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dark, tarry, or bloody stools; fainting; fast or irregular heartbeat; feeling cold, especially in the hands or feet; fever, chills, or sore throat; pale skin; severe or persistent dizziness; shortness of breath; unusual bruising or bleeding; unusual tiredness or weakness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Boceprevir side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Boceprevir in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Boceprevir may also be stored at room temperature up to 77 degrees F (25 degrees C) for 3 months. Keep Boceprevir in the original container. Avoid exposure to excessive heat. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Boceprevir out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Boceprevir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Memotropil may be available in the countries listed below.
Piracetam is reported as an ingredient of Memotropil in the following countries:
International Drug Name Search
Generic Name: barium sulfate (oral and rectal) (BER ee um SUL fate)
Brand Names: Anatrast, Baricon, Baro-Cat, Barosperse, CheeTah, CheeTah Butterscotch, CheeTah Chocolaty-Fudge, CheeTah Orange, CheeTah Raspberry, E-Z AC, E-Z Dose Kit with Polibar Plus, E-Z-Cat, E-Z-HD, E-Z-Paque, Eneset 2, Entero-H, Entrobar, Esopho-Cat, Liqui-Coat HD, Liquid Polibar, Medebar Plus, Medebar Super 250, Readi-Cat, Readi-Cat 2, Scan C, Smoothie Readi-Cat 2, Sol-O-Pake, Tonojug, Tonopaque, Varibar Nectar, Varibar Pudding, Varibar Thin, Varibar Thin Honey, Volumen
Barium sulfate is in a group of drugs called contrast agents. Barium sulfate works by coating the inside of your esophagus, stomach, or intestines which allows them to be seen more clearly on a CT scan or other radiologic (x-ray) examination.
Barium sulfate is used to help diagnose certain disorders of the esophagus, stomach, or intestines.
Barium sulfate may also be used for purposes not listed in this medication guide.
Before you use barium sulfate, tell your doctor if you have any allergies, or if you have asthma, cystic fibrosis, heart disease or high blood pressure, rectal cancer, a colostomy, a blockage in your stomach or intestines, a condition called pseudotumor cerebri, or if you have recently had a rectal biopsy or surgery on your esophagus, stomach, or intestines.
Carefully follow your doctor's instructions about what to eat or drink within the 24-hour period before your test.
To make sure you can safely use barium sulfate, tell your doctor if you have any of these other conditions:
asthma, eczema, or allergies;
a blockage in your stomach or intestines;
cystic fibrosis;
a colostomy;
rectal cancer;
heart disease or high blood pressure;
Hirsch sprung's disease (a disorder of the intestines);
a condition called pseudotumor cerebri (high pressure inside the skull that may cause headaches, vision loss, or other symptoms);
a recent history of surgery on your esophagus, stomach, or intestines;
a history of perforation (a hole or tear) in your esophagus, stomach, or intestines;
if you have recently had a rectal biopsy;
if you have ever choked on food by accidentally inhaling it into your lungs;
if you are allergic to simethicone (Gas-X, Phazyme, and others); or
if you are allergic to latex rubber.
Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.
Barium sulfate comes in tablets, paste, cream, or liquid forms.
In some cases, barium sulfate is taken by mouth. The liquid form may also be used as a rectal enema.
You may need to begin using this medication at home a day before your medical test. Follow your doctor's instructions about how much of the medication to use and how often.
If you are receiving barium sulfate as a rectal enema, a healthcare professional will give you the medication at the clinic or hospital where your testing will take place.
Dissolve the barium sulfate powder in a small amount of water. Stir this mixture and drink all of it right away. To make sure you get the entire dose, add a little more water to the same glass, swirl gently and drink right away.
Carefully follow your doctor's instructions about what to eat or drink within the 24-hour period before your test.
If you are using barium sulfate at home, call your doctor for instructions if you miss a dose.
Overdose symptoms may include severe stomach pain, ongoing diarrhea, confusion, or weakness.
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
severe stomach pain;
severe cramping, diarrhea, or constipation;
sweating;
ringing in your ears;
confusion, fast heart rate; or
pale skin, weakness.
Less serious side effects may include:
mild stomach cramps;
nausea, vomiting;
loose stools or mild constipation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with barium sulfate. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Barotrast side effects (in more detail)
In the US, Acetadote (acetylcysteine systemic) is a member of the following drug classes: antidotes, mucolytics and is used to treat Acetaminophen Overdose.
US matches:
Acetylcysteine is reported as an ingredient of Acetadote in the following countries:
International Drug Name Search
Class: Opiate Agonists
VA Class: CN101
CAS Number: 8002-76-4
Brands: B & O
Opiate agonist and antiperistaltic agent; naturally occurring phenanthrene derivative; contains several alkaloids, including anhydrous morphine, codeine, and papaverine.a b c d g h
Used rectally in combination with belladonna extract for the relief of moderate to severe pain associated with ureteral spasm unresponsive to nonopiate analgesics.a d
Used when the analgesic, sedative, and antispasmodic effects of the combination may be useful (i.e., when pain and smooth-muscle spasm are present concurrently)a and to space intervals between opiate injections.d
Paregoric or opium tincture are used principally for the treatment of diarrhea.a b g h
Should not be used for treatment of diarrhea caused by poisoning until the toxic material is eliminated from the GI tract by gastric lavage or cathartics.b g h (See Contraindications.)
Used as a tincture (e.g., paregoric or diluted opium tincture) to treat opiate withdrawal† symptoms (e.g., generalized tremors, hypertonicity with any form of tactile stimuli, hyperalertness, sleeplessness, excessive crying, vomiting, diarrhea, yawning, fever) in neonates† born to women addicted to opiates.a b c
Diluted opium tincture is preferred by some clinicians to paregoric tincture for the treatment of opiate withdrawal symptoms in neonates, since paregoric contains camphor and benzoic acid which may cause potential adverse effects.b
Administer orally as a solution.b g h
Administer rectally as a suppository.a d
Paregoric and opium tincture are administered orally as a solution.b g h
Opium tincture contains 25 times more morphine than does paregoric and should never be confused with the latter preparation.b f (See Concentrated Opium Solutions and also Possible Prescribing and Dispensing Errors, under Cautions.)
For treatment of opiate withdrawal symptoms in neonates, opium tincture must be diluted and administered as a 1:25 dilution in water.b
Opium is administered rectally as a suppository in combination with belladonna extract.a d
Moisten finger and rectal suppository containing belladonna and opium with water prior to rectal insertion.a d
Tincture: Available as opium and paregoric; dosage is expressed in terms of anhydrous morphine alkaloid.b f g h i
Opium tincture is an alcoholic solution containing 50 mg of anhydrous morphine (as granulated or sliced opium) per 5 mL.b h
Paregoric contains 2 mg of anhydrous morphine (usually as opium), anise oil, benzoic acid, glycerin, and sufficient diluted alcohol to make 5 mL.b g
Rectal suppository: Available as a fixed combination containing opium and belladonna; dosage expressed in terms of opium and belladonna.d
Should be given in the smallest effective dose and as infrequently as possible to minimize the development of tolerance and physical dependence.a c h
Usually, 0.25–0.5 mL/kg 1–4 times daily.b g
To prevent potential overdose, opium tincture must be diluted and administered as a 1:25 dilution in water.b (See Concentrated Opium Solutions and also Possible Prescribing and Dispensing Errors, under Cautions.)
Neonates†: Usually, 3–6 drops every 3–6 hours as needed; adjust dosage to control withdrawal symptoms.b Alternatively, initially, 0.2 mL every 3 hours and increase, if necessary, by approximately 0.05 mL every 3 hours until withdrawal symptoms are controlled; rarely necessary to exceed 0.7 mL per dose.b After withdrawal symptoms have stabilized for 3–5 days, gradually decrease dosage over a 2- to 4-week period.b c
Usually, 1 suppository once or twice daily, or as directed by a clinician.a d
Usually, 5–10 mL 1–4 times daily.b g
Opium tincture contains 25 times more morphine than does paregoric and should never be confused with the latter preparation.b f (See Concentrated Opium Solutions and also Possible Prescribing and Dispensing Errors, under Cautions.)
Usually, 0.6 mL 4 times daily;b h may range from 0.3–1 mL 4 times daily.b
Neonates†: Rarely necessary to exceed 0.7 mL per dose.b
Maximum 1 suppository 4 times daily.d
Maximum 1 mL as a single dose or 6 mL daily.b
Use with caution and reduce initial dosage in patients with hepatic cirrhosis or insufficiency.b c g h
Use with caution and reduce initial dosage in patients with renal impairment.c g
Administer with caution and reduce dosage in geriatric or debilitated patients.b c d g h
Known hypersensitivity to opium or morphine.c g
Convulsive states (e.g., status epilepticus, tetanus, strychnine poisoning).d g
Undiluted opium tincture: Children.h (See Pediatric Use under Cautions.)
Paregoric and opium tincture: Diarrhea caused by poisoning until the toxic material is eliminated from the GI tract.g h
Opium and belladonna combination suppository: Glaucoma, severe renal or hepatic disease, bronchial asthma, respiratory depression, acute alcoholism, delirium tremens, premature labor.d
Abuse potential exists; use with caution.d g h
Does not produce analgesia or euphoria in usual oral antidiarrheal doses; therefore, opium preparations may be used in the treatment of acute diarrhea with little risk of development of physical dependence in the patient.b However, prolonged use of opium preparations (e.g., patients with ileitis or colitis) may produce physical dependence.b g
Use with caution in patients with a history of opiate agonist dependence.b
Mild withdrawal symptoms reported in patients receiving paregoric 10 mg every 4 hours for 1–2 weeks.g Provide supportive care in a hospital setting for patients in opiate withdrawal.g
Serious adverse events and deaths have occurred when opium tincture was mistakenly interchanged for paregoric (also known as “camphorated tincture of opium” and “tincture of paregoric”).f These medication errors resulted in fatal adverse events because opium tincture is 25 times more concentrated than paregoric.f FDA recommends a poison label for all containers of opium tincture stating the strength of morphine per mL and a statement such as “WARNING! Do NOT confuse opium tincture with paregoric.”f
Ensure accuracy of prescription spelling; similarity in acronyms for diluted tincture of opium and deodorized tincture of opium (e.g., DTO), which contains 25 times more opium.e May result in fatal errors.e
It is important that prescriptions for opium preparations be written clearly and filled with the proper concentration to prevent potential medication errors.e
Respiratory depressant effects (with CO2 retention and secondary elevation of CSF pressure) may be markedly exaggerated in the presence of head injury, other intracranial lesions, or a preexisting increase in intracranial pressure.g h
May produce effects that obscure the clinical course in patients with head injuries.g
Use with extreme caution, if at all, in patients with a head injury, brain tumor, or elevated CSF pressure.c
Like all opiate analgesics, may cause severe hypotension in the postoperative patient or any individual whose ability to maintain their BP is compromised by a depleted blood volume or concomitant drugs (e.g., phenothiazines, general anesthetics).c g
May produce orthostatic hypotension in ambulatory patients.c Lightheadedness and dizziness appear to be more prominent in ambulatory patients; may be alleviated if the patient lies down.g
Respiratory depression requiring administration of naloxone or ventilatory support may result from toxic dosages.d g
May decrease respiratory drive to the point of apnea while simultaneously increasing airway resistance, even at usual therapeutic doses.g Use with extreme caution in patients with disorders characterized by hypoxia.g
Use with caution in patients with asthma or emphysema.b c
Administration may complicate assessment of patients with acute abdominal conditions.g
Reduce the initial dosage in patients who have undergone GI surgery.c Use with caution in patients with GI hemorrhage.h
May impair mental and/or physical abilities needed to perform potentially hazardous activities such as driving or operating machinery.c g Individuals who perform hazardous tasks requiring mental alertness or physical coordination should be warned about possible adverse CNS effects of opiate agonists.c g
May aggravate preexisting seizures in patients with convulsive disorders.c g Risk of seizures in patients without a history of seizure disorders at dosages above recommended levels.g
Use with caution in patients with severe prostatic hypertrophy or urethral stricture.b d g
Use with caution and reduce the initial dosage in patients with hypothyroidism.c g
Use with caution in patients with untreated myxedema.c h
Use with caution and reduce the initial dosage in patients with Addison’s disease.c g
May increase ventricular response rate through a vagolytic action; use with caution in patients with atrial flutter or other supraventricular tachycardias.c g
Use with caution in patients with cerebral arteriosclerosis.h
Consider the cautions, precautions, and contraindications associated with other drug(s) in fixed-combination preparations.a d h
Category C.d g h
Morphine is distributed into milk.g Use with caution in nursing women.d g h
Manufacturer does not recommend use of opium rectal suppositories in children ≤12 years of age.d
Manufacturer does not recommend use of opium tincture in children;h however, diluted opium tincture has been used to treat opiate withdrawal† symptoms in neonates† born to women addicted to opiates.a c
Use with caution in geriatric patients.d g
Use with caution in patients with severe hepatic impairment.d g
Use with caution in patients with severe renal impairment.d g
Opium tincture and fixed-combination suppositories: Constipation,d h nausea,d h vomiting.d h
Paregoric: Lightheadedness,g dizziness,g sedation,g nausea,g vomiting.g
Drug | Interaction | Comments |
|---|---|---|
CNS depressants (other opiates, general anesthetics, tranquilizers, sedatives, hypnotics, alcohol) | May potentiate the effects of other CNS depressantsc g | Use concomitantly with great caution and in reduced dosagea c g h Some tranquilizers, especially phenothiazines, may antagonize opiate agonist analgesiac |
Diuretics | Opiate agonists may decrease the effects of diuretics in patients with CHFc | |
Opiate partial agonists (butorphanol, nalbuphine, pentazocine) | Possible reduced analgesic effect and/or withdrawal symptoms | Avoid concomitant use |
Skeletal muscle relaxants | May enhance the neuromuscular blocking action of skeletal muscle relaxantsc |
Following oral administration, morphine is variably absorbed from the GI tract.a b h
Following rectal administration, analgesia occurs in 15–30 minutes.a
Following rectal administration, analgesia is maintained for 3–5 hours.a
Metabolized principally in the liver and undergoes conjugation with glucuronic acid.a b c h
Secondary conjugation may also occur to form 3,6-diglucuronide.a b h
Excreted principally in urine as metabolites and to a lesser extent as unchanged drug.a b h
Approximately 75% of morphine excreted in the urine within 48 hours.a b h
Paregoric: Tight, light-resistant containers at 15–30°C.b g A sediment may form if exposed to low temperatures; filter if necessary.g Avoid exposure to direct sunlight and to excessive heat.b
Opium tincture: Tight, light-resistant containers at 15–30° C.b h Avoid exposure to direct sunlight and to excessive heat.b
Room temperature.d Do not refrigerate.d Protect from moisture.d
Analgesic activity results primarily from the morphine content of opium preparations.a d h
Increases smooth muscle tone in the longitudinal muscle of the GI tract, inhibits GI motility and propulsive contraction, and diminishes digestive secretions.b h
Relatively small doses of opium are effective in controlling diarrhea, but do not produce substantial analgesia.a b h
Papaverine content of the mixed alkaloids is too small to have demonstrable smooth muscle relaxant activity.a b h
Importance of informing patients that drug may impair mental and/or physical ability required for performance of potentially hazardous tasks.c g
Importance of informing patients that opium preparations should not be combined with alcohol or other CNS depressants (e.g., sleep medications, tranquilizers).g h
Importance of informing patients that this is a drug of potential abuse.d g h
Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, as well as any concomitant illnesses.g
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.g h
Importance of informing patients of other important precautionary information. (See Cautions.)
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Opium preparations are subject to control under the Federal Controlled Substances Act of 1970 as schedule II (C-II) drugs, but as schedule III (C-III) drugs when they contain ≤25 mg of opium per 5 mL, 5 g, or dosage unit in fixed combination with a therapeutic amount of one or more nonopiate drugs or as schedule V (C-V) drugs when they contain 1 mg or less of opium per mL or g in combination with one or more active nonopiate medicinal ingredients in sufficient proportion to confer on the preparation medicinal qualities not possessed by opium.a b
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Bulk | Powder |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Rectal | Suppositories | 30 mg with Belladonna Extract 16.2 mg (equivalent to belladonna alkaloids 0.21 mg)* | B&O Supprettes No. 15A (C-II) | Amerifit |
60 mg with Belladonna Extract 16.2 mg (equivalent to belladonna alkaloids 0.21 mg)* | B&O Supprettes No. 16A (C-II) | Amerifit |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Oral | Tincture | 50 mg (of morphine anhydrous) per 5 mL* | Opium Tincture Deodorized (C-II) | Marathon |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Oral | Tincture* | 2 mg (of morphine anhydrous) per 5 mL* | Paregoric (C-III) |
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions May 01, 2009. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
† Use is not currently included in the labeling approved by the US Food and Drug Administration.
a. AHFS Drug Information 2007. McEvoy GK, ed. Opium. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 2152.
b. AHFS Drug Information 2007. McEvoy GK, ed. Opium Preparations. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 2917-8.
c. AHFS Drug Information 2007. McEvoy GK, ed. Opiate Agonists General Statement. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 2123-28.
d. Paddock Laboratories. Belladonna & opium rectal suppositories prescribing information. Minneapolis, MN; Undated.
e. Food and Drug Administration. Drug Errors Caused by Abbreviations. FDA Patient Safety News: Show #15. FDA Patient Safety News May 2003. From FDA web site .
f. Food and Drug Administration. Dangerous Mixups Between Opium Tincture and Paregoric. FDA Patient Safety News: Show #27, May 2004. From FDA web site.
g. Actavis. Paregoric (camphorated opium tincture) [Morphine anhydrous (opium 2 mg)] prescribing information. Baltimore, MD; 2006 Feb.
h. Ranbaxy. Opium tincture (deodorized) prescribing information. Jacksonville, FL; 2004 Dec.
i. Code of federal regulations. Part 1304.31. Reports from manufacturers importing narcotic raw material. Revised as of April 1, 2006.
Terbinafin Arrow may be available in the countries listed below.
Terbinafine is reported as an ingredient of Terbinafin Arrow in the following countries:
International Drug Name Search
Lisinopril HCT Atid may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Lisinopril HCT Atid in the following countries:
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril HCT Atid in the following countries:
International Drug Name Search
Sedam may be available in the countries listed below.
Bromazepam is reported as an ingredient of Sedam in the following countries:
International Drug Name Search
Melatonina Sundown may be available in the countries listed below.
Melatonin is reported as an ingredient of Melatonina Sundown in the following countries:
International Drug Name Search
Sicotral may be available in the countries listed below.
Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Sicotral in the following countries:
International Drug Name Search
Definition of Constipation: Constipation refers to infrequent or hard stools, or difficulty passing stools. More specifically, constipation may involve pain during the passage of a bowel movement, the inability to pass a bowel movement after straining or pushing for more than 10 minutes, or no bowel movements after more than 3 days.
The following drugs and medications are in some way related to, or used in the treatment of Constipation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Micromedex Care Notes:
Medical Encyclopedia:
